VYNE Therapeutics (VYNE) EBT Margin (QoQ) (2017 - 2025)
VYNE Therapeutics (VYNE) EBT Margin (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -144,550.00 |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | -442,277.00 |
| Sep 30, 2024 | -530,216.00 |
| Jun 30, 2024 | 149,605.00 |
| Mar 31, 2024 | 185,374.00 |
| Dec 31, 2023 | -276,930.00 |
| Sep 30, 2023 | 471,256.00 |
| Jun 30, 2023 | -442,600.00 |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | -2.12 Mn |
| Sep 30, 2022 | 99,380.00 |
| Jun 30, 2022 | -165,144.00 |
| Mar 31, 2022 | -165,350.00 |
| Dec 31, 2021 | 750,307.00 |
| Sep 30, 2021 | -711,180.00 |
| Jun 30, 2021 | 110,666.00 |
| Mar 31, 2021 | -418,784.00 |
| Dec 31, 2020 | 21,513.00 |
| Sep 30, 2020 | 67,882.00 |